- Home
- IINN vs IBIO Comparison
IINN vs IBIO Comparison
Compare IINN & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- IBIO
- Stock Information
- Founded
- IINN 2018
- IBIO 2008
- Country
- IINN Israel
- IBIO United States
- Employees
- IINN N/A
- IBIO N/A
- Industry
- IINN Medical/Dental Instruments
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- IBIO Health Care
- Exchange
- IINN Nasdaq
- IBIO Nasdaq
- Market Cap
- IINN 15.9M
- IBIO 24.3M
- IPO Year
- IINN 2021
- IBIO N/A
- Fundamental
- Price
- IINN $0.59
- IBIO $0.89
- Analyst Decision
- IINN
- IBIO Strong Buy
- Analyst Count
- IINN 0
- IBIO 3
- Target Price
- IINN N/A
- IBIO $4.87
- AVG Volume (30 Days)
- IINN 322.0K
- IBIO 720.0K
- Earning Date
- IINN 04-29-2025
- IBIO 05-12-2025
- Dividend Yield
- IINN N/A
- IBIO N/A
- EPS Growth
- IINN N/A
- IBIO N/A
- EPS
- IINN N/A
- IBIO N/A
- Revenue
- IINN N/A
- IBIO $375,000.00
- Revenue This Year
- IINN N/A
- IBIO $36.00
- Revenue Next Year
- IINN N/A
- IBIO $33.33
- P/E Ratio
- IINN N/A
- IBIO N/A
- Revenue Growth
- IINN N/A
- IBIO 650.00
- 52 Week Low
- IINN $0.54
- IBIO $1.03
- 52 Week High
- IINN $2.45
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- IINN 32.65
- IBIO 18.58
- Support Level
- IINN $0.55
- IBIO $1.08
- Resistance Level
- IINN $0.70
- IBIO $1.33
- Average True Range (ATR)
- IINN 0.07
- IBIO 0.37
- MACD
- IINN 0.00
- IBIO -0.21
- Stochastic Oscillator
- IINN 27.54
- IBIO 0.60
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.